Fails 1 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published. The answers and the pharmacy partners page say every batch is tested by an independent laboratory, with no document behind the claim.
At a glance
TeleClinicTelehealth service
7/8criteria passed
Price
Semaglutide $79 the first month, standard rate $199 a month; tirzepatide $149, standard $299
Sells
compounded semaglutide, compounded tirzepatide, NAD+ injection, and 1 more
Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.
A New York telehealth platform selling compounded semaglutide and tirzepatide, NAD+ injections and a B12 with MIC lipotropic injection, prescribed by independent physicians from a contracted network. Care starts with a free online questionnaire, and prescriptions are filled by Rush Pharmacy.
The evidence behind each disposition in the table above, where it appears, and its date.
S1PASSA licensed physician reviews each intake and decides whether the patient is a candidate, and the terms say every prescription is issued at the independent physician's discretion. The medical team page says the physicians come from the LocumTele network and are not named publicly.Source: TeleClinic's medical team article; TeleClinic's terms of service page; TeleClinic's website.
S2PASSThe home page and each treatment page say care starts with a free online questionnaire that a physician reviews, and that a buyer who is not prescribed is not charged; the refund policy says any charge taken before that decision is refunded.Source: TeleClinic's website; TeleClinic's compounded semaglutide product page; TeleClinic's refund policy.
S3PASSThe pharmacy partners page and the answers say all prescriptions are filled by Rush Pharmacy, a licensed 503A compounding pharmacy. No street address is printed for it.Source: TeleClinic's pharmacy partners article; TeleClinic's FAQ.
S4PASSThe disclaimer at the foot of every page states that compounded medications dispensed through its partner pharmacies are not FDA-approved, and the terms and the pharmacy partners page say the same.Source: TeleClinic's website; TeleClinic's terms of service page; TeleClinic's pharmacy partners article.
S5FAILNo certificate of analysis or lot document is published. The answers and the pharmacy partners page say every batch is tested by an independent laboratory, with no document behind the claim.Source: TeleClinic's pharmacy partners article; TeleClinic's FAQ.
S6PASSTeleclinic Holdings LLC at 447 Broadway, 2nd Floor #3505, New York, NY 10013, printed as the mailing address on the contact page and in the terms, the privacy policy and the refund and shipping policies. The terms name New York law.Source: TeleClinic's contact page; TeleClinic's terms of service page; TeleClinic's privacy policy.
S7PASSCompounded semaglutide at an introductory $79 for the first month or $179 for the first three months, and compounded tirzepatide at $149 for the first month or $399 for the first three months. The answers page gives an introductory rate for the first quarter of $139 a month for semaglutide against a standard rate of $199, and $219 for tirzepatide against a standard rate of $299, and the home page prints the same $139 and $199. NAD+ at an introductory $99 for the first month against a struck-through $129, or $250 for three months against $319. The B12 with MIC injection at $109 a month, or $84 a month for the first quarter, billed $252, then $109. A one-time consultation fee of $25 may apply in some states.Source: TeleClinic's compounded semaglutide product page; TeleClinic's compounded tirzepatide product page; TeleClinic's FAQ; TeleClinic's website; TeleClinic's NAD+ injection product page; TeleClinic's B12 MIC lipotropic product page.
S8PASSNo FDA warning letter names TeleClinic or Teleclinic Holdings LLC, and no action has halted the business.Source: FDA warning-letter index.
Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, NAD+ injection, B12 + MIC lipotropic.
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.